Cannabis News and Research

Latest Cannabis News and Research

Psychoactive ingredient in marijuana may impair ability to produce viable embryos

Female eggs exposed to THC, the psychoactive ingredient in marijuana, have an impaired ability to produce viable embryos, and are significantly less likely to result in a viable pregnancy, according to an animal study accepted for presentation at ENDO 2020, the Endocrine Society's annual meeting.

2 Apr 2020

Teen marijuana use associated with insomnia later on

Smoke a lot of weed as a teenager, and when you reach adulthood you'll be more likely to have trouble falling or staying asleep, according to a new University of Colorado Boulder study of more than 2,000 twins.

31 Mar 2020

Online coronavirus tests are just the latest iffy products marketed to anxious consumers

Companies with experience in the "at-home" testing market began announcing in mid-March that they would be offering direct-to-consumer test kits for COVID-19.

31 Mar 2020

Pittcon 2020 a Success in Chicago

2020 Conference and Exposition Continued for the Sake of Science

From Pittcon 31 Mar 2020

Scientists could soon develop saliva test for measuring cannabis levels in impaired drivers

In the U.S., those who consume alcohol and drive are often subjected to roadside stops, breathalyzer tests and stiff penalties if their blood alcohol content exceeds certain limits.

31 Mar 2020

Study sheds light on common adverse reactions to cannabis

Coughing fits, anxiety and paranoia are three of the most common adverse reactions to cannabis, according to a recent study by Washington State University researchers.

30 Mar 2020

Handy homogeniser for cannabis sample preparation

The Chromatrap Spin Column Homogeniser from Porvair Sciences is gaining considerable interest from organizations preparing Cannabis samples for analysis of Tetrahydrocannabinol and Cannabidiol.

From Chromatrap® - Porvair Sciences Ltd 30 Mar 2020

Study shows legal marijuana products too strong for pain relief

Most legal marijuana products supplied to medical dispensaries are stronger than recommended for treatment of chronic pain.

26 Mar 2020

Accurate and informative labeling of CBD products is a critical public health issue

The need for accurate and informative labeling of hemp and hemp-derived cannabidiol (CBD) products is a critical public health issue.

25 Mar 2020

Mapping the cannabis genome to improve agriculture and human health

Unlocking the full potential of cannabis for agriculture and human health will require a co-ordinated scientific effort to assemble and map the cannabis genome, says a just-published international study led by University of Saskatchewan researchers.

25 Mar 2020

Vaporized cannabis increases drug-seeking behavior, study shows

Rats with regular access to cannabis seek more of the substance and tend to show increased drug-seeking behavior when cannabis is absent.

24 Mar 2020

Cannabidiol helps fight antibiotic-resistant bacteria

Since the discovery of penicillin in 1928 by Sir Alexander Fleming, antibiotics have saved millions of lives from fatal infections world-wide. However, with time bacteria have developed mechanisms to escape the effects of antibiotics - they have become resistant.

24 Mar 2020

Using cannabinoids for management of acute pain

A new systematic review and meta-analysis showed a small but significant reduction in subjective pain scores for cannabinoid treatment compared to placebo in patients experiencing acute pain.

23 Mar 2020

Why is the tobacco industry supporting wider access to medical cannabis?

A new study published in the BMJ reveals disturbing connections between organizations and groups that are lobbying for broader access to medical cannabis and those who are fighting for the legalization of recreational cannabis. This raises questions as to the reasons behind the industry’s support for measures that will make it easier for patients to gain access to medical cannabis – is it because of the knowledge that by so doing, they will also be able to market the drug for recreational use in the UK?

18 Mar 2020

UCLA researcher awarded NIH grant to study pain-relieving effects of cannabis chemicals

Ziva Cooper, research director of the UCLA Cannabis Research Initiative, has been awarded a $3.9 million grant from the National Center for Complementary and Integrative Health at the NIH to study whether cannabis chemicals called terpenes can reduce the amount of opioid medication a person needs to reduce pain.

18 Mar 2020

How effective is Gabapentin in alcohol use disorder?

A new study published in the journal JAMA Internal Medicine in March 2020 reports the striking efficacy of the drug gabapentin in helping people with alcohol use disorder (AUD) with their alcohol withdrawal symptoms.

9 Mar 2020

Study looks at lung injury and vaping THC and vitamin E acetate

The US has witnessed a spate of patients presenting with acute lung injury associated with e-cigarettes or vaping product use. A new study published in the journal JAMA Internal Medicine shows the pattern of the outbreak in California where recreational cannabis use is legal and which has among the maximum cases of the strange illness.

8 Mar 2020

Fears prevent vaping to help smokers to quit

According to a new report from the Public Health England (PHE) published this week, more and more people are not using e-cigarettes to quit traditional smoking due to fears about the harm the former cause.

5 Mar 2020

Cannabis use more prevalent among pregnant women with depression

Cannabis use is much more common among pregnant women with depression and pregnant women with depression are more than 3 times more likely to use cannabis than those without depression, according to a new study at Columbia University Mailman School of Public Health.

3 Mar 2020

How cannabis interacts with medications

A new practice guideline published in the journal CMAJ in February 2020 describes five types of drug interactions possible with the use of cannabis. Cannabis is a plant-derived drug containing the psychoactive ingredient delta-9-tetrahydrocannabinol (THC) and non-psychoactive cannabidiol (CBD). These cannabinoids are broken down by the liver enzymes cytochrome P450 C(YP)34A, and CYP2CC9.

2 Mar 2020